title: Gastrointestinal Conditions in the Obese Patient.
abstract: Obesity in adolescents presents many challenges for the patient, family, and physician. The myriad problems involving the GI tract will be managed more effectively when the treating physician has an understanding of the presentations, pathophysiology, appropriate laboratory evaluation, and approaches to treatment for these complications. In addition to being familiar with the pharmacotherapeutic options available, having an approach to behavioral change, such as MI, can be an extremely useful tool.
authors.forename: Sharonda Alston
authors.initials: SA
authors.lastname: Taylor
authors.forename: Ryan
authors.initials: R
authors.lastname: Himes
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Hastings
authors.forename: Beth
authors.initials: B
authors.lastname: Garland
mesh_terms: D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D019440:Anti-Obesity Agents / Q000009:adverse effects; D003248:Constipation / Q000150:complications; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D004066:Digestive System Diseases / Q000139:chemically induced / Q000150:complications*; D005242:Fecal Incontinence / Q000150:complications; D042882:Gallstones / Q000150:complications; D005764:Gastroesophageal Reflux / Q000150:complications; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007783:Lactones / Q000009:adverse effects; D008687:Metformin / Q000009:adverse effects; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications; D000077403:Orlistat; D010195:Pancreatitis / Q000150:complications; D063766:Pediatric Obesity / Q000150:complications* / Q000601:surgery
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019440:Anti-Obesity Agents; D003277:Contraceptives, Oral, Combined; D007004:Hypoglycemic Agents; D007783:Lactones; D008687:Metformin; D000077403:Orlistat